glp-1 stomach acid Indigestion from Injections Heartburn and GLP-1 Treatments
Description
J Endocrinol (2014) 221(1):T3141
Wright and his team are at the forefront of this research, working to provide effective treatments for those affected by lipedema
Careful preclinical safety assessments and early-phase clinical trials are required to determine tolerability
Exposed women were older with a higher mean BMI of 34 for women exposed to liraglutide compared to 23 for unexposed women, and a mean BMI of 33 for women exposed to semaglutide compared to 24 for unexposed women (equal to 47.837.5% higher BMI, for liraglutide and semaglutide exposure, respectively)
